Skip to main content
. 2020 Apr 7;18(3):282–288. doi: 10.5217/ir.2019.09140

Fig. 1.

Fig. 1.

Survival after cancer diagnosis compared between patients exposed or not exposed to TNF inhibitors (TNFi). The probability of accelerated mortality did not significantly differ between the TNFi exposed and TNFi naïve groups. χ²(1)=0.0, P=0.985.